Viridien
Short position disclosed on September 21, 2026.
8.08% of the capital sold short
9 disclosing funds
2,488 disclosures on record
Evolution of the disclosed total
0%2.5%5%7.5%10%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Capital Fund Management | 1.52% | +0.95 pt | September 15, 2026 | ||
| Marshall Wace LLP | 1.32% | -0.13 pt | September 18, 2026 | ||
| Citadel Advisors LLC | 1.12% | +0.34 pt | September 21, 2026 | ||
| Worldquant, LLC | 0.90% | new | September 16, 2026 | ||
| Walleye Capital LLC | 0.71% | new | August 17, 2026 | AMF | |
| TWO Sigma Investments, LP | 0.70% | new | August 19, 2026 | AMF | |
| Tudor Capital Europe LLP | 0.70% | new | September 21, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF | |
| Acadian Asset Management LLC | 0.54% | new | September 17, 2026 |
In the United States CGPVF (OTC): 3,771 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| October 15, 2024 | Qube Research & Technologies Limited | 2.10% | January 23, 2025 | |
| October 4, 2024 | Qube Research & Technologies Limited | 2.09% | January 23, 2025 | |
| September 26, 2024 | Citadel Securities (Europe) Limited | 0.57% | October 29, 2024 | |
| September 24, 2024 | Citadel Securities (Europe) Limited | 0.60% | October 29, 2024 | |
| September 18, 2024 | Capital Fund Management | 0.48% | September 20, 2024 | |
| September 10, 2024 | Citadel Securities (Europe) Limited | 0.51% | October 29, 2024 | |
| September 5, 2024 | Qube Research & Technologies Limited | 2.18% | January 23, 2025 | |
| August 29, 2024 | Capital Fund Management | 0.54% | September 20, 2024 | |
| August 19, 2024 | Marshall Wace LLP | 0.99% | March 24, 2025 | |
| August 13, 2024 | Millennium International Management LP | 0.47% | August 15, 2024 | |
| August 9, 2024 | Qube Research & Technologies Limited | 2.26% | January 23, 2025 | |
| August 8, 2024 | Marshall Wace LLP | 1.07% | March 24, 2025 | |
| August 6, 2024 | Qube Research & Technologies Limited | 2.32% | January 23, 2025 | |
| August 5, 2024 | Millennium International Management LP | 0.55% | August 15, 2024 | |
| August 2, 2024 | Qube Research & Technologies Limited | 2.24% | January 23, 2025 | |
| August 2, 2024 | Marshall Wace LLP | 1.10% | March 24, 2025 | |
| August 1, 2024 | Qube Research & Technologies Limited | 2.12% | January 23, 2025 | |
| August 1, 2024 | Marshall Wace LLP | 1.05% | March 24, 2025 | |
| August 1, 2024 | Millennium International Management LP | 0.66% | August 15, 2024 | |
| July 31, 2024 | Marshall Wace LLP | 0.98% | March 24, 2025 | |
| July 31, 2024 | Millennium International Management LP | 0.00% | August 2, 2024 | |
| July 30, 2024 | Qube Research & Technologies Limited | 2.04% | January 23, 2025 | |
| July 30, 2024 | Marshall Wace LLP | 1.09% | March 24, 2025 | |
| July 29, 2024 | Qube Research & Technologies Limited | 1.97% | January 23, 2025 | |
| July 26, 2024 | Qube Research & Technologies Limited | 1.86% | January 23, 2025 | |
| July 24, 2024 | Qube Research & Technologies Limited | 1.90% | January 23, 2025 | |
| July 23, 2024 | Marshall Wace LLP | 1.11% | March 24, 2025 | |
| July 22, 2024 | Millennium International Management LP | 0.51% | August 2, 2024 | |
| July 19, 2024 | Qube Research & Technologies Limited | 1.80% | January 23, 2025 | |
| July 19, 2024 | Marshall Wace LLP | 1.05% | March 24, 2025 | |
| July 19, 2024 | Millennium International Management LP | 0.49% | July 23, 2024 | |
| July 18, 2024 | Qube Research & Technologies Limited | 1.75% | January 23, 2025 | |
| July 18, 2024 | Millennium International Management LP | 0.50% | July 23, 2024 | |
| July 15, 2024 | Qube Research & Technologies Limited | 1.81% | January 23, 2025 | |
| July 12, 2024 | Qube Research & Technologies Limited | 1.77% | January 23, 2025 | |
| July 11, 2024 | Qube Research & Technologies Limited | 1.80% | January 23, 2025 | |
| July 10, 2024 | Qube Research & Technologies Limited | 1.76% | January 23, 2025 | |
| July 8, 2024 | Qube Research & Technologies Limited | 1.65% | January 23, 2025 | |
| June 28, 2024 | Marshall Wace LLP | 0.96% | March 24, 2025 | |
| June 26, 2024 | Qube Research & Technologies Limited | 1.59% | January 23, 2025 | |
| June 25, 2024 | Marshall Wace LLP | 1.08% | March 24, 2025 | |
| June 21, 2024 | Qube Research & Technologies Limited | 1.69% | January 23, 2025 | |
| June 21, 2024 | Marshall Wace LLP | 1.16% | March 24, 2025 | |
| June 20, 2024 | Qube Research & Technologies Limited | 1.70% | January 23, 2025 | |
| June 19, 2024 | Qube Research & Technologies Limited | 1.69% | January 23, 2025 | |
| June 13, 2024 | Qube Research & Technologies Limited | 1.75% | January 23, 2025 | |
| June 12, 2024 | Qube Research & Technologies Limited | 1.63% | January 23, 2025 | |
| June 10, 2024 | Qube Research & Technologies Limited | 1.59% | January 23, 2025 | |
| June 5, 2024 | Qube Research & Technologies Limited | 1.65% | January 23, 2025 | |
| June 3, 2024 | Qube Research & Technologies Limited | 1.52% | January 23, 2025 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 2488 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
- DBV Technologies 3.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at September 21, 2026, https://www.quivad.com/action/viridien?page=7